|
Toward a Science of Consciousness 2012
PLENARY
Robin Carhart-Harris, PhD
Neuropsychopharmacology Unit
Imperial College London
After an MA in Psychoanalysis at Brunel University, London, Carhart-Harris completed his PhD in psychopharmacology at the University of Bristol. In 2009, under the mentorship of Professor David Nutt, Carhart-Harris moved to Imperial College London to continue his fMRI research with the classic psychedelic drug psilocybin (magic mushrooms). Over the last four years Carhart-Harris & Nutt have built up a programme of research with psychedelics that includes fMR and MEG imaging with psilocybin, fMR imaging with MDMA and soon an MRC-sponsored clinical trial to assess the efficacy of psilocybin as a treatment for major depression. Carhart-Harris has a review article published in Brain on the neurobiology of Freudian constructs and his work with psilocybin is now published in PNAS and the British Journal of Psychiatry with several other relevant papers to follow. Carhart-Harris has been supported by the Beckley foundation (UK) and the Neuropsychoanalysis Foundation, Heffter Foundation and MAPS (US).
------------------------------------------
From the Current PNAS Cover: Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin
Robin L. Carhart-Harris, David Erritzoe, Tim Williams, James M. Stone, Laurence J. Reed, Alessandro Colasanti, Robin J. Tyacke, Robert Leech, Andrea L. Malizia, Kevin Murphy, Peter Hobden, John Evans, Amanda Feilding, Richard G. Wise, and David J. Nutt
Proc. Natl. Acad. Sci. USA. 2012; 109:2138-2143.
.
|